2015 – Co-chairing the Clinical TMS Society’s meeting in Toronto

Dr. Cochran co-chaired the annual meeting of the Clinical TMS Society with Dr. Paul Croarkin and was able to get to know Dr. Johnny O’Reardon who was the principal investigator for the Neuronetics Randomized Controlled Trial that led to the FDA clearance of TMS for Depression.